AbbVie Inc. - 8-K Filing
AbbVie reports Q3 2026 net revenues of $17.4B, up 10.3% YoY, and raises full-year adjusted EPS guidance. (Items: 2.02 Results of Operations and Financial Condition On October 30, 2026, AbbVie Inc, 9.01 Financial Statements and Exhibits(d) ExhibitsExhibit No)
Tickers: $ABBV
Read the full article at SEC EDGAR
Part of the story UNITY BANCORP INC /NJ/ - 8-K Filing (116 articles)